Information:
Fel:
ID
29332
Beskrivning
Study part: Language Used for Patient- Reported Outcome Questionnaires Day 0. A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection Compared With Sham In Subjects with Macular Edema Secondary To Branch Retinal Vein Occlusion.
Nyckelord
Versioner (1)
- 2018-03-18 2018-03-18 -
Rättsinnehavare
Roche
Uppladdad den
18 mars 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Language Used for Patient- Reported Outcome Questionnaires Day 0 Ranibizumab Macular Edema Secondary To Branch Retinal Vein Occlusion FVF4165g
Language Used for Patient- Reported Outcome Questionnaires Day 0
- StudyEvent: ODM
Similar models
Language Used for Patient- Reported Outcome Questionnaires Day 0
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
LANGUAGE USED FOR PATIENT-REPORTED OUTCOME QUESTIONNAIRES (DAY 0)
C0023008 (UMLS CUI-1)
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Item
In what language will the patient-reported outcome questionnaires be administered (NEI VFQ-25 AND OARS)?
text
C0023008 (UMLS CUI [1])
Code List
In what language will the patient-reported outcome questionnaires be administered (NEI VFQ-25 AND OARS)?
CL Item
English (English)
C0376245 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Spanish (Spanish)
C0037750 (UMLS CUI-1)
(Comment:en)
(Comment:en)